Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2021
Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than <i>BRCA1</i> or <i>BRCA2</i>Mark Robson
Lancet (London, England)|August 9, 2003
The place for politics?Mark Robson
Nature Clinical Practice. Oncology|December 22, 2006
Is breast conservation a reasonable option for women with BRCA-associated breast cancer?Mark Robson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?Mark Robson
Hematology/Oncology Clinics of North America|November 26, 2022
Testing for Inherited Susceptibility to Breast CancerMark Robson
Ecotoxicology and Environmental Safety|August 14, 2003
Methodologies for assessing exposures to metals: human host factorsMark Robson
Clinical Breast Cancer|October 28, 2004
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutationsMark Robson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Multigene panel testing: planning the next generation of research studies in clinical cancer geneticsMark Robson
Hematology/Oncology Clinics of North America|September 7, 2010
Inherited predisposition to cancer: introduction and overviewMark Robson, Kenneth Offit
Nature Reviews. Clinical Oncology|July 22, 2015
Breast cancer: oophorectomy for BRCA1 ER--negative disease-an open debateNoah Kauff, Mark Robson
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2021
Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than <i>BRCA1</i> or <i>BRCA2</i>Mark Robson
Lancet (London, England)|August 9, 2003
The place for politics?Mark Robson
Nature Clinical Practice. Oncology|December 22, 2006
Is breast conservation a reasonable option for women with BRCA-associated breast cancer?Mark Robson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?Mark Robson
Hematology/Oncology Clinics of North America|November 26, 2022
Testing for Inherited Susceptibility to Breast CancerMark Robson
Ecotoxicology and Environmental Safety|August 14, 2003
Methodologies for assessing exposures to metals: human host factorsMark Robson
Clinical Breast Cancer|October 28, 2004
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutationsMark Robson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Multigene panel testing: planning the next generation of research studies in clinical cancer geneticsMark Robson
Hematology/Oncology Clinics of North America|September 7, 2010
Inherited predisposition to cancer: introduction and overviewMark Robson, Kenneth Offit
Nature Reviews. Clinical Oncology|July 22, 2015
Breast cancer: oophorectomy for BRCA1 ER--negative disease-an open debateNoah Kauff, Mark Robson
Pageof 22